Guggenheim upgraded Exelon to Buy from Neutral with a $45 price target. The firm cites valuation, on both a relative and absolute basis, coupled with a higher growth trajectory than the peer average. The firm also cites its views on the “relatively straightforward” second half catalyst pathway as it argues that “simplicity has value in this market” and its favorable views of management coming off detailed meetings several weeks ago.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>